Business Context and Reporting Period
This Form 6-K filing by GSK plc covers the month of December 2022. The report serves as a notification to the market regarding the Company's total voting rights and capital structure in conformity with the Financial Conduct Authority's Disclosure Guidance and Transparency Rule 5.6.1R.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on share capital and voting rights data.
| Metric | Value |
|---|---|
| Issued Share Capital (as of Nov 30, 2022) | 4,311,323,324 Ordinary Shares (31 1/2 pence each) |
| Treasury Shares | 243,924,760 |
| Total Voting Rights | 4,067,398,564 |
Material Changes
The filing text does not provide a clear value for material changes versus the prior comparable period. The document reports a static snapshot of share capital as of November 30, 2022, without comparative historical data.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is a regulatory notification regarding shareholder voting thresholds.
Important Facts for Investors to Verify
- Confirm the total number of voting rights (4,067,398,564) to calculate disclosure thresholds under FCA rules.
- Verify the number of shares held in Treasury (243,924,760) which are excluded from voting rights.
- Note that this filing does not contain financial performance data; refer to Form 20-F for financial results.